Medical treatment of fragile X syndrome;Tratamiento médico del síndrome X frágil

Revista de Neurologia

Volumn 33, Issue SUPPL. 1, 2001, Pages

  Artigas Pallares J ^a  

^a HOSPITAL DE SABADELL   (Spain)

Author keywords

Attention hyperactive deficit; Fragile x syndrome; Mental retardation; Psycopharmacology

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTICONVULSIVE AGENT; CENTRAL STIMULANT AGENT; CLONIDINE; FOLIC ACID; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; EPILEPSY; FRAGILE X SYNDROME; HUMAN; MENTAL DEFICIENCY; PATHOPHYSIOLOGY;

ADRENERGIC ALPHA-AGONISTS; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CLONIDINE; EPILEPSY; FOLIC ACID; FRAGILE X SYNDROME; HUMANS; MENTAL RETARDATION; SEROTONIN UPTAKE INHIBITORS;

EID: 11244314131     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Riddle MA, Kastelic EA, Frosch E. Pediatric psychopharmacology. J Child Psychol Psychiatry 2001; 42: 73-90.
2. Hyperlink: [http://www.dianetics.org/dnhmspn.htm]
3. Conners CK. Rating scales in attention-deficit/hyperactivity disorder: use in assessment and treatment monitoring. J Clin Psychiatry 1998; 59: 24-30.
4. Barkley RA. Defiant children. 2nd edition. New York: The Guilford Press; 1997.
5. Achenbach TM, Edelbrock CS. Manual for the Child Behavior Profile and Child Behavior Checklist. Burlington, VT: Thomas Achenbach; 1986.
6. Artigas-Pallarés J, Brun-Gasca C, Gabau E. Aspectos médicos y neuropsicológicos del sindrome X frágil. Rev Neural Clin 2001; 2:42-54.
7. Moore SJ, Strain L, Cole GF, Miedzybrodzka Z, Kelly KF, Dean JC. Fragile X syndrome with FMR1 and FMR2 deletion. J Med Genet 1999; 36: 565-6.